Skip to content

Carlsmed, Inc. Common Stock CARL Q4 2025 Annual earnings

Reported February 25, 2026 · After market close

Revenue estimate$14.7M
EPS estimate-$0.43

Next report

Jul 21, 2026 (In 3 weeks)
Revenue estimate$18.0M
EPS estimate-$0.43

Financials

Q4 2025

Income statement

See full
Revenue$15.2M+61.2%
Gross profit$11.6M+65.3%
Operating income-$9.3M-98.4%
Net income-$8.6M-82.5%

Balance sheet

See full
Cash & equivalents$85.8M+114%
Total debt$17.4M+1.4%
Total equity$98.9M+240%
Total assets$130.1M+151%

Cash flow

See full
Operating cash flow-$5.3M-26.6%
CapEx$73.0K+19.7%
Free cash flow-$5.4M-26.5%

Valuation & ratios

Valuation

as of 12/31/25
See full
Market cap$328.42M
Enterprise value$260.04M
P/S6.5×

Profitability

See full
Gross margin75.3%+1.5pp
Operating margin-60.5%-14.6pp
Net margin-58.7%-15.0pp
FCF margin-58.6%

Returns & leverage

See full
Debt / equity0.2×
Current ratio8.9×+3.3×

Versus estimates

Ask the moment Carlsmed, Inc. Common Stock reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Carlsmed, Inc. Common Stock report Q4 2025 earnings?
Carlsmed, Inc. Common Stock (CARL) reported Q4 2025 earnings on February 25, 2026 after market close.
What were Carlsmed, Inc. Common Stock's Q4 2025 revenue and EPS?
Carlsmed, Inc. Common Stock reported revenue of $15.2M and diluted EPS of $-0.32 for Q4 2025.
Did Carlsmed, Inc. Common Stock beat estimates in Q4 2025?
Revenue beat the consensus estimate of $14.7M by $443.8K. EPS beat the consensus estimate of $-0.43 by $0.11.
Where can I find Carlsmed, Inc. Common Stock's Q4 2025 SEC filings?
You can read the 8-K earnings release (0001193125-26-071512) and the 10-K periodic report (0001193125-26-071551) directly on SEC EDGAR. The filing index links above go to sec.gov.